These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8709119)

  • 1. (2E)-5-[3-[(phenylsulfonyl)amino]phenyl]-pent-2-en-4-ynohydroxamic acid and its derivatives as novel and potent inhibitors of ras transformation.
    Ohtani M; Matsuura T; Shirahase K; Sugita K
    J Med Chem; 1996 Jul; 39(15):2871-3. PubMed ID: 8709119
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth-suppressive activities of serine protease inhibitors, ONO-3403 and ONO-5046, toward normal and transformed murine fibroblasts.
    Hiwasa T; Ohkoshi M
    Anticancer Res; 1996; 16(4A):1823-6. PubMed ID: 8712707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel series of highly selective inhibitors of MMP-3.
    Whitlock GA; Dack KN; Dickinson RP; Lewis ML
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6750-3. PubMed ID: 18029177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of potential antitumor agents. Synthesis and biological evaluation of a new set of sulfonamide derivatives as histone deacetylase inhibitors.
    Bouchain G; Leit S; Frechette S; Khalil EA; Lavoie R; Moradei O; Woo SH; Fournel M; Yan PT; Kalita A; Trachy-Bourget MC; Beaulieu C; Li Z; Robert MF; MacLeod AR; Besterman JM; Delorme D
    J Med Chem; 2003 Feb; 46(5):820-30. PubMed ID: 12593661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sultam hydroxamates as novel matrix metalloproteinase inhibitors.
    Cherney RJ; Mo R; Meyer DT; Hardman KD; Liu RQ; Covington MB; Qian M; Wasserman ZR; Christ DD; Trzaskos JM; Newton RC; Decicco CP
    J Med Chem; 2004 Jun; 47(12):2981-3. PubMed ID: 15163180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acquisition of contact inhibition in ras-oncogene transformant by fucoidan from marine algae].
    Takahashi N; Machiguchi Y; Sato N; Ohnishi R; Nishikawa K; Wada Y; Cho JM; Miyake H; Kikuchi K
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):405-7. PubMed ID: 1543369
    [No Abstract]   [Full Text] [Related]  

  • 7. beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.
    Yang SM; Scannevin RH; Wang B; Burke SL; Wilson LJ; Karnachi P; Rhodes KJ; Lagu B; Murray WV
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1135-9. PubMed ID: 18086526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potent Ras signaling inhibitors by pathway-selective phenotype-based screening.
    Müller O; Gourzoulidou E; Carpintero M; Karaguni IM; Langerak A; Herrmann C; Möröy T; Klein-Hitpass L; Waldmann H
    Angew Chem Int Ed Engl; 2004 Jan; 43(4):450-4. PubMed ID: 14735532
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel compound, depudecin, induces production of transformation to the flat phenotype of NIH3T3 cells transformed by ras-oncogene.
    Sugita K; Yoshida H; Matsumoto M; Matsutani S
    Biochem Biophys Res Commun; 1992 Jan; 182(1):379-87. PubMed ID: 1731795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 2. Optimization of alpha-amino substituents.
    Yang SM; Scannevin RH; Wang B; Burke SL; Huang Z; Karnachi P; Wilson LJ; Rhodes KJ; Lagu B; Murray WV
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1140-5. PubMed ID: 18083558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRF-1 reverts the transformed phenotype of oncogenically transformed cells in vitro and in vivo.
    Kröger A; Dallügge A; Kirchhoff S; Hauser H
    Oncogene; 2003 Feb; 22(7):1045-56. PubMed ID: 12592391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The isolated catalytic hairpin of the Ras-specific guanine nucleotide exchange factor Cdc25Mm retains nucleotide dissociation activity but has impaired nucleotide exchange activity.
    Sacco E; Fantinato S; Manzoni R; Metalli D; De Gioia L; Fantucci P; Alberghina L; Vanoni M
    FEBS Lett; 2005 Dec; 579(30):6851-8. PubMed ID: 16325815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxamic acid-based bisubstrate analog inhibitors of Ras farnesyl protein transferase.
    Patel DV; Young MG; Robinson SP; Hunihan L; Dean BJ; Gordon EM
    J Med Chem; 1996 Oct; 39(21):4197-210. PubMed ID: 8863797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship studies of novel oxygen-incorporated SAHA analogues.
    Kim SA; Jin YL; Kim HS
    Arch Pharm Res; 2009 Jan; 32(1):15-21. PubMed ID: 19183872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of alpha2(I) collagen, a suppressor of Ras transformation, is required for stable phenotypic reversion by farnesyltransferase inhibitors.
    Du W; Lebowitz PF; Prendergast GC
    Cancer Res; 1999 May; 59(9):2059-63. PubMed ID: 10232587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras.
    Gapuzan ME; Schmah O; Pollock AD; Hoffmann A; Gilmore TD
    Oncogene; 2005 Sep; 24(43):6574-83. PubMed ID: 16027734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of the transformed phenotype and inhibition of peptidylglycine alpha-monooxygenase in Ras-transformed cells by 4-phenyl-3-butenoic acid.
    Sunman JA; Foster MS; Folse SL; May SW; Matesic DF
    Mol Carcinog; 2004 Dec; 41(4):231-46. PubMed ID: 15468302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of transformed phenotypes of Ha-ras-transformed NIH3T3 cells by caspase-2.
    Hiwasa T; Nakagawara A
    Biochem Biophys Res Commun; 1998 Sep; 250(3):741-6. PubMed ID: 9784416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ChoK is an efficient antitumor strategy for Harvey-, Kirsten-, and N-ras-transformed cells.
    Ramírez de Molina A; Rodríguez-González A; Penalva V; Lucas L; Lacal JC
    Biochem Biophys Res Commun; 2001 Jul; 285(4):873-9. PubMed ID: 11467831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of 3-(4-substituted-phenyl)-N-hydroxy-2-propenamides, a new class of histone deacetylase inhibitors.
    Kim DK; Lee JY; Kim JS; Ryu JH; Choi JY; Lee JW; Im GJ; Kim TK; Seo JW; Park HJ; Yoo J; Park JH; Kim TY; Bang YJ
    J Med Chem; 2003 Dec; 46(26):5745-51. PubMed ID: 14667227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.